Literature DB >> 32832836

Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry.

Marco Matejcic1, Yesha Patel1, Jenna Lilyquist2, Chunling Hu3, Kun Y Lee2,3, Rohan D Gnanaolivu2, Steven N Hart2, Eric C Polley2, Siddhartha Yadav4, Nicholas J Boddicker2, Raed Samara5, Lucy Xia1, Xin Sheng1, Alexander Lubmawa6, Vicky Kiddu6, Benon Masaba7, Dan Namuguzi8, George Mutema9, Kuteesa Job10, Dabanja M Henry11, Sue A Ingles1, Lynne Wilkens12, Loic Le Marchand12, Stephen Watya6,8, Fergus J Couch2,3, David V Conti1, Christopher A Haiman1.   

Abstract

PURPOSE: In studies of men of European ancestry, rare pathogenic variants in DNA repair pathway genes have been shown to be associated with risk of aggressive prostate cancer. The contribution of rare coding variation to prostate cancer risk in men of African ancestry has not been established.
METHODS: We sequenced a panel of 19 DNA repair and cancer predisposition genes in 2,453 African American and 1,151 Ugandan prostate cancer cases and controls. Rare variants were classified as pathogenic or putatively functionally disruptive and examined in association with prostate cancer risk and disease aggressiveness in gene and pathway-level association analyses.
RESULTS: Pathogenic variants were found in 75 out of 2,098 cases (3.6%) and 31 out of 1,481 controls (2.1%) (OR=1.82, 95% CI=1.19 to 2.79, P=0.0044) with the association being stronger for more aggressive disease phenotypes (OR=3.10, 95% CI=1.54 to 6.23, P=0.0022). The highest risks for aggressive disease were observed with pathogenic variants in the ATM, BRCA2, PALB2 and NBN genes, with odds ratios ranging from ~4 to 15 in the combined study sample of African American and Ugandan men. Rare, non-pathogenic, non-synonymous variants did not have a major impact on risk of overall prostate cancer or disease aggressiveness.
CONCLUSIONS: Rare pathogenic variants in DNA repair genes have appreciable effects on risk of aggressive prostate cancer in men of African ancestry. These findings have potential implications for panel testing and risk stratification in this high-risk population.

Entities:  

Year:  2020        PMID: 32832836      PMCID: PMC7442213          DOI: 10.1200/po.19.00179

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN: 2473-4284


  27 in total

Review 1.  Human DNA repair genes, 2005.

Authors:  Richard D Wood; Michael Mitchell; Tomas Lindahl
Journal:  Mutat Res       Date:  2005-09-04       Impact factor: 2.433

2.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

4.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

Authors:  L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

5.  dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs.

Authors:  Xiaoming Liu; Chunlei Wu; Chang Li; Eric Boerwinkle
Journal:  Hum Mutat       Date:  2016-01-05       Impact factor: 4.878

6.  Prostate cancer incidence rates in Africa.

Authors:  Lisa W Chu; Jamie Ritchey; Susan S Devesa; Sabah M Quraishi; Hongmei Zhang; Ann W Hsing
Journal:  Prostate Cancer       Date:  2011-08-01

7.  Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.

Authors:  Martina Mijuskovic; Edward J Saunders; Daniel A Leongamornlert; Sarah Wakerell; Ian Whitmore; Tokhir Dadaev; Clara Cieza-Borrella; Koveela Govindasami; Mark N Brook; Christopher A Haiman; David V Conti; Rosalind A Eeles; Zsofia Kote-Jarai
Journal:  Br J Cancer       Date:  2018-06-19       Impact factor: 7.640

8.  CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.

Authors:  Márton Münz; Elise Ruark; Anthony Renwick; Emma Ramsay; Matthew Clarke; Shazia Mahamdallie; Victoria Cloke; Sheila Seal; Ann Strydom; Gerton Lunter; Nazneen Rahman
Journal:  Genome Med       Date:  2015-07-28       Impact factor: 11.117

9.  ClinVar: public archive of interpretations of clinically relevant variants.

Authors:  Melissa J Landrum; Jennifer M Lee; Mark Benson; Garth Brown; Chen Chao; Shanmuga Chitipiralla; Baoshan Gu; Jennifer Hart; Douglas Hoffman; Jeffrey Hoover; Wonhee Jang; Kenneth Katz; Michael Ovetsky; George Riley; Amanjeev Sethi; Ray Tully; Ricardo Villamarin-Salomon; Wendy Rubinstein; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

10.  Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Authors:  Tokhir Dadaev; Edward J Saunders; Paul J Newcombe; Ezequiel Anokian; Daniel A Leongamornlert; Mark N Brook; Clara Cieza-Borrella; Martina Mijuskovic; Sarah Wakerell; Ali Amin Al Olama; Fredrick R Schumacher; Sonja I Berndt; Sara Benlloch; Mahbubl Ahmed; Chee Goh; Xin Sheng; Zhuo Zhang; Kenneth Muir; Koveela Govindasami; Artitaya Lophatananon; Victoria L Stevens; Susan M Gapstur; Brian D Carter; Catherine M Tangen; Phyllis Goodman; Ian M Thompson; Jyotsna Batra; Suzanne Chambers; Leire Moya; Judith Clements; Lisa Horvath; Wayne Tilley; Gail Risbridger; Henrik Gronberg; Markus Aly; Tobias Nordström; Paul Pharoah; Nora Pashayan; Johanna Schleutker; Teuvo L J Tammela; Csilla Sipeky; Anssi Auvinen; Demetrius Albanes; Stephanie Weinstein; Alicja Wolk; Niclas Hakansson; Catharine West; Alison M Dunning; Neil Burnet; Lorelei Mucci; Edward Giovannucci; Gerald Andriole; Olivier Cussenot; Géraldine Cancel-Tassin; Stella Koutros; Laura E Beane Freeman; Karina Dalsgaard Sorensen; Torben Falck Orntoft; Michael Borre; Lovise Maehle; Eli Marie Grindedal; David E Neal; Jenny L Donovan; Freddie C Hamdy; Richard M Martin; Ruth C Travis; Tim J Key; Robert J Hamilton; Neil E Fleshner; Antonio Finelli; Sue Ann Ingles; Mariana C Stern; Barry Rosenstein; Sarah Kerns; Harry Ostrer; Yong-Jie Lu; Hong-Wei Zhang; Ninghan Feng; Xueying Mao; Xin Guo; Guomin Wang; Zan Sun; Graham G Giles; Melissa C Southey; Robert J MacInnis; Liesel M FitzGerald; Adam S Kibel; Bettina F Drake; Ana Vega; Antonio Gómez-Caamaño; Laura Fachal; Robert Szulkin; Martin Eklund; Manolis Kogevinas; Javier Llorca; Gemma Castaño-Vinyals; Kathryn L Penney; Meir Stampfer; Jong Y Park; Thomas A Sellers; Hui-Yi Lin; Janet L Stanford; Cezary Cybulski; Dominika Wokolorczyk; Jan Lubinski; Elaine A Ostrander; Milan S Geybels; Børge G Nordestgaard; Sune F Nielsen; Maren Weisher; Rasmus Bisbjerg; Martin Andreas Røder; Peter Iversen; Hermann Brenner; Katarina Cuk; Bernd Holleczek; Christiane Maier; Manuel Luedeke; Thomas Schnoeller; Jeri Kim; Christopher J Logothetis; Esther M John; Manuel R Teixeira; Paula Paulo; Marta Cardoso; Susan L Neuhausen; Linda Steele; Yuan Chun Ding; Kim De Ruyck; Gert De Meerleer; Piet Ost; Azad Razack; Jasmine Lim; Soo-Hwang Teo; Daniel W Lin; Lisa F Newcomb; Davor Lessel; Marija Gamulin; Tomislav Kulis; Radka Kaneva; Nawaid Usmani; Chavdar Slavov; Vanio Mitev; Matthew Parliament; Sandeep Singhal; Frank Claessens; Steven Joniau; Thomas Van den Broeck; Samantha Larkin; Paul A Townsend; Claire Aukim-Hastie; Manuela Gago-Dominguez; Jose Esteban Castelao; Maria Elena Martinez; Monique J Roobol; Guido Jenster; Ron H N van Schaik; Florence Menegaux; Thérèse Truong; Yves Akoli Koudou; Jianfeng Xu; Kay-Tee Khaw; Lisa Cannon-Albright; Hardev Pandha; Agnieszka Michael; Andrzej Kierzek; Stephen N Thibodeau; Shannon K McDonnell; Daniel J Schaid; Sara Lindstrom; Constance Turman; Jing Ma; David J Hunter; Elio Riboli; Afshan Siddiq; Federico Canzian; Laurence N Kolonel; Loic Le Marchand; Robert N Hoover; Mitchell J Machiela; Peter Kraft; Matthew Freedman; Fredrik Wiklund; Stephen Chanock; Brian E Henderson; Douglas F Easton; Christopher A Haiman; Rosalind A Eeles; David V Conti; Zsofia Kote-Jarai
Journal:  Nat Commun       Date:  2018-06-11       Impact factor: 14.919

View more
  10 in total

1.  Prostate Cancer Genomics Research Disparities in Africa: Advancing Knowledge in Resource Constrained Settings.

Authors:  Pedro W Fernandez
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

2.  PALB2 mutations and prostate cancer risk and survival.

Authors:  Dominika Wokołorczyk; Wojciech Kluźniak; Klaudia Stempa; Bogna Rusak; Tomasz Huzarski; Jacek Gronwald; Katarzyna Gliniewicz; Aniruddh Kashyap; Sylwia Morawska; Tadeusz Dębniak; Anna Jakubowska; Marek Szwiec; Paweł Domagała; Jan Lubiński; Steven A Narod; Mohammad R Akbari; Cezary Cybulski
Journal:  Br J Cancer       Date:  2021-05-18       Impact factor: 7.640

3.  Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic study.

Authors:  Kosj Yamoah; Francis A Asamoah; Afua O D Abrahams; Shivanshu Awasthi; James E Mensah; Jasreman Dhillon; Brandon A Mahal; Serigne Magueye Gueye; Mohamed Jalloh; Sahar J Farahani; Priti Lal; Timothy R Rebbeck; Joel Yarney
Journal:  Prostate       Date:  2021-09-16       Impact factor: 4.104

4.  Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.

Authors:  Burcu F Darst; Xin Sheng; Rosalind A Eeles; Zsofia Kote-Jarai; David V Conti; Christopher A Haiman
Journal:  Eur Urol       Date:  2021-05-01       Impact factor: 24.267

5.  DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.

Authors:  Anna Plym; Miklós Dióssy; Zoltan Szallasi; Oliver Sartor; Jonathan Silberstein; Isaac J Powell; Timothy R Rebbeck; Kathryn L Penney; Lorelei A Mucci; Mark M Pomerantz; Adam S Kibel
Journal:  JNCI Cancer Spectr       Date:  2021-12-27

6.  Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.

Authors:  Indu Kohaar; Xijun Zhang; Shiv Srivastava; Gyorgy Petrovics; Shyh-Han Tan; Darryl Nousome; Kevin Babcock; Lakshmi Ravindranath; Gauthaman Sukumar; Elisa Mcgrath-Martinez; John Rosenberger; Camille Alba; Amina Ali; Denise Young; Yongmei Chen; Jennifer Cullen; Inger L Rosner; Isabell A Sesterhenn; Albert Dobi; Gregory Chesnut; Clesson Turner; Clifton Dalgard; Matthew D Wilkerson; Harvey B Pollard
Journal:  Nat Commun       Date:  2022-03-15       Impact factor: 14.919

7.  BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis.

Authors:  Tommy Nyberg; Marc Tischkowitz; Antonis C Antoniou
Journal:  Br J Cancer       Date:  2021-12-28       Impact factor: 9.075

8.  Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.

Authors:  Daniel J Lee; Ryan Hausler; Anh N Le; Gregory Kelly; Jacquelyn Powers; James Ding; Emily Feld; Heena Desai; Casey Morrison; Abigail Doucette; Peter Gabriel; Regeneron Genetics Center; Renae L Judy; Joellen Weaver; Rachel Kember; Scott M Damrauer; Daniel J Rader; Susan M Domchek; Vivek Narayan; Lauren E Schwartz; Kara N Maxwell
Journal:  Eur Urol       Date:  2021-10-25       Impact factor: 24.267

9.  Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.

Authors:  Burcu F Darst; Tokhir Dadaev; Ed Saunders; Xin Sheng; Peggy Wan; Loreall Pooler; Lucy Y Xia; Stephen Chanock; Sonja I Berndt; Susan M Gapstur; Victoria Stevens; Demetrius Albanes; Stephanie J Weinstein; Vincent Gnanapragasam; Graham G Giles; Tu Nguyen-Dumont; Roger L Milne; Mark Pomerantz; Julie A Schmidt; Lorelei Mucci; William J Catalona; Kurt N Hetrick; Kimberly F Doheny; Robert J MacInnis; Melissa C Southey; Rosalind A Eeles; Fredrik Wiklund; Zsofia Kote-Jarai; David V Conti; Christopher A Haiman
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

10.  Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.

Authors:  Questa Karlsson; Mark N Brook; Tokhir Dadaev; Sarah Wakerell; Edward J Saunders; Kenneth Muir; David E Neal; Graham G Giles; Robert J MacInnis; Stephen N Thibodeau; Shannon K McDonnell; Lisa Cannon-Albright; Manuel R Teixeira; Paula Paulo; Marta Cardoso; Chad Huff; Donghui Li; Yu Yao; Paul Scheet; Jennifer B Permuth; Janet L Stanford; James Y Dai; Elaine A Ostrander; Olivier Cussenot; Géraldine Cancel-Tassin; Josef Hoegel; Kathleen Herkommer; Johanna Schleutker; Teuvo L J Tammela; Venkat Rathinakannan; Csilla Sipeky; Fredrik Wiklund; Henrik Grönberg; Markus Aly; William B Isaacs; Jo L Dickinson; Liesel M FitzGerald; Melvin L K Chua; Tu Nguyen-Dumont; Daniel J Schaid; Melissa C Southey; Rosalind A Eeles; Zsofia Kote-Jarai
Journal:  Eur Urol Oncol       Date:  2021-01-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.